🎙 New Podcast Episode Released!
📖 Newly published in the
@JCardFail and presented at
#THT2025, a retrospective analysis using the Premier Healthcare Database (PHD), an all-payer database, demonstrated a large and significant reduction in hospital visits and length of stay in
#Barostim patients with
#heartfailure and reduced ejection fraction.1,2 Join
@Abraham_Jacob, MD and Philip Adamson, MD as they provide their perspectives on this real-world evidence and its implications for heart failure management.
Listen now:
lnkd.in/gHhF35Hd
ISI:
barost.im/ISI
1. Abraham J, et al. Real-world analysis of healthcare utilization with baroreflex activation therapy for heart failure, JC ard Fail 2025 (online ahead of print). 2. Hospital length-of-stay was compared 12 months pre-implant and 12 ± 3 months post-implant; p<0.05 for length-of-stay